News – Page 108 – Endpoints News

FDA approves subcutaneous Ocrevus, broadening access to Roche and Genentech blockbuster

8 months ago

WHO pre-qualifies Bavarian Nordic’s vaccine as first mpox shot

8 months ago

Online stimulant prescriptions soared during Covid pandemic, study finds

8 months ago

Valneva raises about €61M; Immuneering details new Phase 2a data

8 months ago

Doug Williams returns with a ‘FIT’ bet on CAR-Ts; Biogen appoints Mene Pangalos to board

8 months ago

Oncternal stops cancer trials and begins search for future business options

8 months ago

Neurocrine culls Phase 2 neuropsych med after failing to validate earlier data

8 months ago

Bicara, Zenas and MBX rekindle IPO market with rare Friday tripleheader

8 months ago

Corrected: Roche’s Tecentriq scores first US approval for subcutaneous PD-L1

8 months ago

Seres' microbiome therapy reduces infections in stem cell transplant patients, but next steps are unclear

8 months ago

FDA revisits new structure for drug review documents, aiming to better explain its decisions

8 months ago

Avadel's narcolepsy drug Lumryz misses PDUFA date, still under review at FDA

8 months ago

FDA should embrace new ways of evaluating rare disease drugs, report argues

8 months ago

Australian RNA manufacturer launches; Forge Biologics’ CEO steps down

8 months ago

Debiopharm, ITM ink up to €300M licensing deal for cancer treatment

8 months ago

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering

8 months ago

Fulcrum's Phase 3 for old GSK drug fails, stock sinks

8 months ago

Charles River to lay off 3% of staffers as it streamlines spending

8 months ago

Sofinnova’s Jim Healy on ‘more rational market’ as four biotech startups near their IPOs

8 months ago

Lilly budgets $1.8B to boost Kisunla, GLP-1 manufacturing in Ireland

8 months ago

Gilead says twice-yearly HIV prevention shot succeeds in second pivotal trial

8 months ago

Noom offers compounded GLP-1 drugs, promises patients can quit and keep weight off

8 months ago

A new startup wants to fight cancer with 'off-the-shelf' gene therapy, securing $26M seed round

8 months ago

F2G inks $100M Series H for another shot at treating fungal infections

8 months ago

First page Previous page 105 106 107108109 110 111 Next page Last page